Endonovo Therapeutics Inc (ENDV) Gross Profit Margin starting from the third quarter 2023 to third quarter 2022, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Endonovo Therapeutics Inc   (ENDV)


Endonovo Therapeutics Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ENDV Gross Profit Margin (Sep 30 2023)
Q3 		(Jun 30 2023)
Q2 		(Mar 31 2023)
Q1 		(Dec 31 2022)
Q4 		(Sep 30 2022)
Q3
Y / Y Revenue Change -86.13 %
Seq. Revenue Change -96.64 %
Revenue In Millions $0.00
Gross Profit Margin 45.59 %
Gross Profit Margin Total Ranking # 2003
Gross Profit In Millions $0.00
Y / Y Gross Profit Change -90 %
Seq. Gross Profit Change -


Commenting Third Quarter 2023 Gross Profit Margin
Endonovo Therapeutics Inc achieved Gross Profit of $0 millions compare to Gross Loss of $0.00 millions booked in the previous quarter. Despite the sequential Revenue deterioration in Q3 of -96.64 % Endonovo Therapeutics Inc managed to reduce Cost of Sales and turn into profitability by achieving a Gross Profit of 0 compare to Gross Loss of $0.00 millions realized in the previous quarter. Company accomplished Gross Profit Margin of 45.59 %, below company average.


Observing third quarter 2023 results within Medical Equipment & Supplies industry 139 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from to 2003.
Learn about Gross Margin
ENDV's Gross Profit Margin third quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 140
Healthcare Sector # 362
Overall # 1976

Gross Profit Margin Statistics
High Average Low
98.35 % 75.51 % 30.31 %
(Jun 30 2021)   (Jun 30 2015)


ENDV Gross Income Trends • More of ENDV's Profitabilty Ratios • ENDV Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
ENDV's Cumulative Gross Profit Margin
Medical Equipment & Supplies Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
ENDV's Gross Profit Margin Profitability versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for ENDV's Competitors
Gross Profit Margin Profit Margin for Endonovo Therapeutics Inc 's Suppliers
Gross Profit Margin Profit Margin for ENDV's Customers

You may also want to know
ENDV's Annual Growth Rates ENDV's Profitability Ratios ENDV's Asset Turnover Ratio ENDV's Dividend Growth
ENDV's Roe ENDV's Valuation Ratios ENDV's Financial Strength Ratios ENDV's Gross Profit Growth
ENDV's Roa ENDV's Inventory Turnover Ratio ENDV's Growth Rates ENDV's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2023, within Medical Equipment & Supplies Industry Gross Profit MarginSep 30 2023 MRQ Gross ProfitSep 30 2023 MRQ Revenue
Longduoduo Co Ltd  96.08 %$ 1.525  Millions$ 1.587  Millions
Catheter Precision Inc   95.49 %$ 0.127  Millions$ 0.133  Millions
Sanara Medtech Inc   93.45 %$ 14.274  Millions$ 15.274  Millions
Semler Scientific inc   93.19 %$ 15.205  Millions$ 16.316  Millions
Venus Concept Inc   92.42 %$ 12.185  Millions$ 13.185  Millions
Vystar Corporation  90.75 %$ 0.055  Millions$ 0.060  Millions
Orchestra Biomed Holdings Inc   90.21 %$ 0.378  Millions$ 0.419  Millions
Cvrx inc   89.82 %$ 8.820  Millions$ 9.820  Millions
Sight Sciences Inc   89.65 %$ 17.332  Millions$ 19.332  Millions
Co diagnostics Inc   89.59 %$ 2.201  Millions$ 2.457  Millions
Vycor Medical Inc   89.53 %$ 0.276  Millions$ 0.309  Millions
Inari Medical Inc   88.88 %$ 111.889  Millions$ 125.889  Millions
Trisalus Life Sciences Inc   88.66 %$ 4.604  Millions$ 5.193  Millions
Shockwave Medical Inc   87.06 %$ 161.507  Millions$ 185.507  Millions
Icad Inc  86.45 %$ 3.521  Millions$ 4.073  Millions
Neuraxis Inc   85.91 %$ 0.410  Millions$ 0.477  Millions
Electrocore Inc   85.34 %$ 3.847  Millions$ 4.508  Millions
Avita Medical Inc   84.51 %$ 11.532  Millions$ 13.645  Millions
Inspire Medical Systems inc   84.31 %$ 128.920  Millions$ 152.920  Millions
Ceribell Inc   83.77 %$ 9.726  Millions$ 11.611  Millions
Nexalin Technology Inc   83.40 %$ 0.020  Millions$ 0.024  Millions
Fonar Corporation  82.87 %$ 21.411  Millions$ 25.838  Millions
Sintx Technologies Inc   82.74 %$ 0.561  Millions$ 0.678  Millions
Mimedx Group Inc   82.70 %$ 66.922  Millions$ 80.922  Millions
Medinotec Inc   82.61 %$ 0.290  Millions$ 0.351  Millions
Paragon 28 inc   80.91 %$ 42.389  Millions$ 52.389  Millions
Zynex inc   80.86 %$ 40.362  Millions$ 49.915  Millions
Axogen inc   80.51 %$ 33.228  Millions$ 41.271  Millions
Treace Medical Concepts Inc   80.38 %$ 32.760  Millions$ 40.758  Millions
Yubo International Biotech Limited  80.30 %$ 0.344  Millions$ 0.429  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.